Infosys Limited INFY recently announced a new collaboration with ValGenesis to bring a stronger compliance and quality management for its healthcare and life sciences sectors’ customers. The partnership will integrate ValGenesis’ Validation Lifecycle Management System (“VLMS”) within Infosys’ suite of services, facilitating delivery of services in a rapidly deployable and highly secure cloud environment.
Touted as a leading paperless validation lifecycle management solution, ValGenesis facilitates automation of full validation process, eliminating inefficiencies in paper-based manual processes, while cutting costs as well as validation cycle times. The VLMS system facilitates delivery of fully configurable and rapidly deployable technology solutions consequently improving a company’s compliance posture. Moreover, the system’s key component, Risk Management, is integrated and flexible offering companies the ability to utilize standard risk tools to efficiently meet their needs.
Existing Business Scenario
Recently, Infosys has been strengthening core competencies by pursuing strategic collaborations and acquisitions. The company’s alliance strategy is targeted at collaborating with leading technology providers, which enables it to take advantage of emerging technologies in a mutually beneficial and cost-competitive manner. Over the past few quarters, the company had partnered with many biggies for reinforcing portfolio as well as market share. Notably, the Zacks Rank #2 (Buy) company’s stock has declined 9.7% in the past three months as against the industry’s growth of 8%.
.jpg)
Moreover, the company’s Renew New strategy is proving to be highly beneficial allowing the company to offset major challenges. The company’s Renew New strategy has helped reap multiple benefits, including renewal of traditional services, winning deals, introduction of services, monetization from key initiatives such as Zero Distance and improvement of employee engagement. Further, the company’s continued focus on commitment to execution has helped it deliver constant currency revenue growth, margin improvement, record cash generation and high revenue per worker over past several quarters.
Furthermore, the company’s services and software are proving conducive to top-line growth. New services, in the cloud first and artificial intelligence (AI) first digital experience service area contributed to 9.4% of revenues during the reported quarter. Software services comprising of Edge, Panaya and Skava resulted in 1.6% of revenue growth during the quarter. Strong demand for these relatively new services is helping Infosys to attain higher growth and margin. This apart, cyber security is one of the company’s prominent profit churners in recent times.
Other Stocks to Consider
Some other top-ranked stocks from the same space include DXC Technology Company DXC, Nutanix Inc. NTNX and Arista Networks, Inc. ANET. While DXC Technology sports a Zacks Rank #1 (Strong Buy), Nutanix and Arista Networks carry a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
DXC Technology has outpaced estimates in the preceding four quarters, with an average earnings surprise of 25.4%.
Nutanix has surpassed estimates in the trailing four quarters, with an average positive earnings surprise of 18.5%.
Arista Networks has surpassed estimates in the preceding four quarters, with an average positive earnings surprise of 27.5%.
Zacks Editor-in-Chief Goes "All In" on This Stock
Full disclosure, Kevin Matras now has more of his own money in one particular stock than in any other. He believes in its short-term profit potential and also in its prospects to more than double by 2019. Today he reveals and explains his surprising move in a new Special Report.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Be the first to comment